Russell Investments Group, Ltd. Karuna Therapeutics, Inc. Transaction History

Russell Investments Group, Ltd.

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 05, 2024	BUY	$161.01 - $317.85 $16,584 - $32,738	103 Added 429.17%	127 $40,000
Q3 2023 Nov 13, 2023	SELL	$164.66 - $218.08 $1.33 Million - $1.77 Million	-8,104 Reduced 99.7%	24 $4,000
Q2 2023 Aug 10, 2023	BUY	$176.32 - $240.22 $449,263 - $612,080	2,548 Added 45.66%	8,128 $1.76 Million
Q1 2023 May 09, 2023	BUY	$161.33 - $204.36 $879,409 - $1.11 Million	5,451 Added 4225.58%	5,580 $1.01 Million
Q3 2022 Nov 04, 2022	SELL	$123.79 - $277.42 $816,395 - $1.83 Million	-6,595 Reduced 98.08%	129 $29,000
Q2 2022 Jul 29, 2022	BUY	$93.97 - $143.33 $142,364 - $217,144	1,515 Added 29.08%	6,724 $849,000
Q1 2022 May 05, 2022	SELL	$98.9 - $132.37 $69,032 - $92,394	-698 Reduced 11.82%	5,209 $659,000
Q4 2021 Jan 21, 2022	BUY	$110.64 - $159.4 $622,681 - $897,103	5,628 Added 2017.2%	5,907 $772,000
Q3 2021 Nov 08, 2021	SELL	$101.2 - $125.87 $73,268 - $91,129	-724 Reduced 72.18%	279 $34,000
Q1 2021 May 10, 2021	SELL	$95.46 - $133.08 $558,631 - $778,784	-5,852 Reduced 85.37%	1,003 $120,000
Q4 2020 Feb 08, 2021	BUY	$75.23 - $109.23 $408,273 - $592,791	5,427 Added 380.04%	6,855 $696,000
Q2 2020 Aug 05, 2020	BUY	$62.14 - $117.21 $88,735 - $167,375	1,428 New	1,428 $159,000

332K

Ticker KRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 33,965,000
Description
Karuna Therapeutics, Inc., a clinical-stage biopharmaceutical company, creates and delivers transformative medicines for people living with psychiatric and neurological conditions. Its lead product candidate is KarXT, an oral modulator of muscarinic receptors that is in Phase III clinical trial for the treatment of acute psychosis in patients wi...

Get notified when there are updates to the investment portfolio of Russell Investments Group, Ltd., based on Form 13F filings with the SEC.

Stay updated on Russell Investments Group, Ltd. with notifications on news.